These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8017432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 6. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, Mazzarella G, Raia V.
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [Abstract] [Full Text] [Related]

  • 7. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Dec; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 8. [Current therapeutic agents: dornase alfa].
    Baran D, Sternon J.
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [Abstract] [Full Text] [Related]

  • 9. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr 15; 36(920):34-5. PubMed ID: 8145672
    [No Abstract] [Full Text] [Related]

  • 10. New treatment for cystic fibrosis.
    Kuhn RJ.
    Am Pharm; 1994 Feb 15; NS34(2):16-8. PubMed ID: 8166040
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.
    VanDevanter DR, Craib ML, Pasta DJ, Millar SJ, Morgan WJ, Konstan MW, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Pediatr Pulmonol; 2018 Jan 15; 53(1):43-49. PubMed ID: 29064184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, Wu M, Chernick MS, Crystal RG.
    N Engl J Med; 1992 Mar 19; 326(12):812-5. PubMed ID: 1538726
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun 19; 63(6):705. PubMed ID: 9687230
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacological and clinical profiles of Dornase alfa (Pulmozyme®) in the management of cystic fibrosis patients to improve pulmonary function].
    Kokubo H, Hosatani S, Ichikawa M.
    Nihon Yakurigaku Zasshi; 2013 Apr 19; 141(4):213-9. PubMed ID: 23575427
    [No Abstract] [Full Text] [Related]

  • 19. FDA approved. New drug bulletin: Cisapride and Dornase alfa.
    RN; 1994 Apr 19; 57(4):39-42. PubMed ID: 8165421
    [No Abstract] [Full Text] [Related]

  • 20. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA, Hilton J, Jepson B, Smith L.
    Pediatrics; 2005 Oct 19; 116(4):e549-54. PubMed ID: 16147970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.